Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype-phenotype correlation.

Published

Journal Article

PURPOSE: Neurofibromatosis type 1 (NF1) is characterized by a highly variable clinical presentation, but almost all NF1-affected adults present with cutaneous and/or subcutaneous neurofibromas. Exceptions are individuals heterozygous for the NF1 in-frame deletion, c.2970_2972del (p.Met992del), associated with a mild phenotype without any externally visible tumors. METHODS: A total of 135 individuals from 103 unrelated families, all carrying the constitutional NF1 p.Met992del pathogenic variant and clinically assessed using the same standardized phenotypic checklist form, were included in this study. RESULTS: None of the individuals had externally visible plexiform or histopathologically confirmed cutaneous or subcutaneous neurofibromas. We did not identify any complications, such as symptomatic optic pathway gliomas (OPGs) or symptomatic spinal neurofibromas; however, 4.8% of individuals had nonoptic brain tumors, mostly low-grade and asymptomatic, and 38.8% had cognitive impairment/learning disabilities. In an individual with the NF1 constitutional c.2970_2972del and three astrocytomas, we provided proof that all were NF1-associated tumors given loss of heterozygosity at three intragenic NF1 microsatellite markers and c.2970_2972del. CONCLUSION: We demonstrate that individuals with the NF1 p.Met992del pathogenic variant have a mild NF1 phenotype lacking clinically suspected plexiform, cutaneous, or subcutaneous neurofibromas. However, learning difficulties are clearly part of the phenotypic presentation in these individuals and will require specialized care.

Full Text

Duke Authors

Cited Authors

  • Koczkowska, M; Callens, T; Gomes, A; Sharp, A; Chen, Y; Hicks, AD; Aylsworth, AS; Azizi, AA; Basel, DG; Bellus, G; Bird, LM; Blazo, MA; Burke, LW; Cannon, A; Collins, F; DeFilippo, C; Denayer, E; Digilio, MC; Dills, SK; Dosa, L; Greenwood, RS; Griffis, C; Gupta, P; Hachen, RK; Hernández-Chico, C; Janssens, S; Jones, KJ; Jordan, JT; Kannu, P; Korf, BR; Lewis, AM; Listernick, RH; Lonardo, F; Mahoney, MJ; Ojeda, MM; McDonald, MT; McDougall, C; Mendelsohn, N; Miller, DT; Mori, M; Oostenbrink, R; Perreault, S; Pierpont, ME; Piscopo, C; Pond, DA; Randolph, LM; Rauen, KA; Rednam, S; Rutledge, SL; Saletti, V; Schaefer, GB; Schorry, EK; Scott, DA; Shugar, A; Siqveland, E; Starr, LJ; Syed, A; Trapane, PL; Ullrich, NJ; Wakefield, EG; Walsh, LE; Wangler, MF; Zackai, E; Claes, KBM; Wimmer, K; van Minkelen, R; De Luca, A; Martin, Y; Legius, E; Messiaen, LM

Published Date

  • April 2019

Published In

Volume / Issue

  • 21 / 4

Start / End Page

  • 867 - 876

PubMed ID

  • 30190611

Pubmed Central ID

  • 30190611

Electronic International Standard Serial Number (EISSN)

  • 1530-0366

Digital Object Identifier (DOI)

  • 10.1038/s41436-018-0269-0

Language

  • eng

Conference Location

  • United States